Inevitability of Voice as a Biomarker

Leveraging over 1 million voice samples from 80,000+ individuals, Sonde Health’s proprietary voice-based technology platform detects changes in user health - like mental fitness and respiratory disease - from changes in voice. Using advanced audio signal processing and machine learning, Sonde senses and analyzes subtle vocal changes due to changes in a person’s physiology to provide early health detection and monitoring. Sonde One, its health screening app, helps large organizations to execute a daily population screening regimen that helps reduce the spread of COVID-19, comply with government mandates, and return to work safely. Sonde has also leveraged its SurveyLex platform to enable rapid voice data collection for large clinical research organizations like UCB Pharma,​ Biogen, Massachusetts General Hospital​, Beth Israel Deaconess Medical Center​, Pear Therapeutics​ etc. and thereafter also enable voice-based health-detection models. Anya Gupta, Sonde's VP of Business Development, will describe the process Sonde has used since inception to develop their vocal biomarker platform.